Publikation
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).
Wissenschaftlicher Artikel/Review - 22.09.2023
Novak Urban, Fehr Martin, Schär Sämi, Dreyling Martin, Schmidt Christian, Derenzini Enrico, Zander Thilo, Hess Georg, Mey Ulrich J M, Ferrero Simone, Mach Nicolas, Boccomini Carola, Böttcher Sebastian, Voegeli Michèle, Cairoli Anne, Ivanova Vanesa-Sindi, Menter Thomas, Dirnhofer Stefan, Scheibe Bernhard, Gadient Sandra, Eckhardt Katrin, Zucca Emanuele, Driessen Christoph, Renner Christoph
Novak, Urban
17
0
Fehr, Martin
Oberarzt mbFMedizinische Onkologie und Hämatologie · Dept. I
17
10
Schär, Sämi
5
0
Dreyling, Martin
1
0
Schmidt, Christian
1
0
Derenzini, Enrico
1
0
Zander, Thilo
9
0
Hess, Georg
Mey, Ulrich J M
6
0
Ferrero, Simone
Mach, Nicolas
11
0
Boccomini, Carola
Böttcher, Sebastian
Voegeli, Michèle
Cairoli, Anne
3
0
Ivanova, Vanesa-Sindi
Menter, Thomas
1
0
Dirnhofer, Stefan
4
0